Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by Liquidtradeon Dec 17, 2020 4:03pm
246 Views
Post# 32130595

RE:Zero revenue at over $1 billion

RE:Zero revenue at over $1 billion
jg75123 wrote: The stock is a joke. The entire stock market is a joke. Who pays a billion dollar valuation for nothing!

ridiculous. Our society has slip into another dimension of stupidity.




You sound like a typical modern day female.
Would you like cheese with your whine?

This is the game. If you don't like it...there is the door....don't let it smack you in the P U S S Y on the way out.

Seriously dude. How long have you been alive for?
If you can't cope, you mine as well rope and evict yourself from your skin suit.

Amazon has never turned a profit.
Tesla skyrocketed before it even sold a single car.

It's all about branding, and it is all about cult.

Mind Med will be like Tesla: A CULT Stock.

Get in or stay the F out.

I've been in since .58 cents......and in the last month..creamed my jeans so much.

You want real problems?
Try getting copious amounts of Jizz and Champagne out of your jeans!
<< Previous
Bullboard Posts
Next >>